Pioglitazone and Metformin
- Generic Name
- Pioglitazone and Metformin
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
适用于单独使用盐酸二甲双胍治疗效果不佳及使用盐酸吡格列酮和盐酸二甲双胍联合治疗的2型糖尿病患者。
- Associated Conditions
- -
- Associated Therapies
- -
Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2014-06-25
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 98
- Registration Number
- NCT02099838
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2010-07-05
- Lead Sponsor
- Takeda
- Target Recruit Count
- 418
- Registration Number
- NCT00772174
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2010-10-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 305
- Registration Number
- NCT00770653
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Takeda
- Target Recruit Count
- 39
- Registration Number
- NCT00770835
Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2010-07-05
- Lead Sponsor
- Takeda
- Target Recruit Count
- 312
- Registration Number
- NCT00754403
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-04
- Last Posted Date
- 2011-07-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 600
- Registration Number
- NCT00727857
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 326
- Registration Number
- NCT00449553
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath